AKT1 and myeloid sarcoma: The PI3K/AKT signaling pathway, which plays an important role in inflammation and glucose‐lipid metabolism, ranked first, indicating it may be the key mechanism underlying ECG's therapeutic effects on MS (Figure 8C).